Navidea Biopharmaceuticals Limited - Dormant company accounts 11.9

Navidea Biopharmaceuticals Limited - Dormant company accounts 11.9

NAVIDEA BIOPHARMACEUTICALS LIMITED - Company Information

Print Friendly Version

07711916 1.8.14 31.7.15 31.7.15 Company accounts Private Limited Company FY true false true false true false false true Ordinary 1.00000 Ordinary 1p 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure077119162014-07-31077119162015-07-31077119162014-08-012015-07-31077119162013-07-31077119162013-08-012014-07-31077119162014-07-3107711916ns12:England2014-08-012015-07-3107711916ns14:PoundSterling2014-08-012015-07-3107711916ns7:Director12014-08-012015-07-3107711916ns7:OrdinaryShareClass12014-08-012015-07-3107711916ns7:OrdinaryShareClass22014-08-012015-07-3107711916ns7:RegisteredOffice2014-08-012015-07-3107711916ns7:OrdinaryShareClass12015-07-3107711916ns7:OrdinaryShareClass12014-07-3107711916ns7:OrdinaryShareClass22015-07-3107711916ns7:OrdinaryShareClass22014-07-31
REGISTERED NUMBER: 07711916 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2015

FOR

NAVIDEA BIOPHARMACEUTICALS LIMITED

NAVIDEA BIOPHARMACEUTICALS LIMITED (REGISTERED NUMBER: 07711916)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2015










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

NAVIDEA BIOPHARMACEUTICALS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JULY 2015







DIRECTOR: W J Regan





REGISTERED OFFICE: 30 Upper High Street
Thame
Oxfordshire
OX9 3EZ





REGISTERED NUMBER: 07711916 (England and Wales)
Page 1
NAVIDEA BIOPHARMACEUTICALS LIMITED (REGISTERED NUMBER: 07711916)

BALANCE SHEET
31 JULY 2015

2015 2014
Notes £    £   
CURRENT ASSETS
Debtors 1 1
TOTAL ASSETS LESS CURRENT
LIABILITIES
1
1

CAPITAL AND RESERVES
Called up share capital 2 1 1
SHAREHOLDERS' FUNDS 1 1

The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the year ended 31 July 2015.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2015 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at
the end of each financial year and of its profit or loss for each financial year in accordance with the
requirements of Sections 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.

These financial statements have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the director on 19 April 2016 and were signed by:





W J Regan - Director


The notes form part of these abbreviated accounts

Page 2
NAVIDEA BIOPHARMACEUTICALS LIMITED (REGISTERED NUMBER: 07711916)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2015


1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance
with the Financial Reporting Standard for Smaller Entities (effective April 2008).

The company was dormant throughout the current year and previous year.

2. CALLED UP SHARE CAPITAL

Allotted and issued:
Number: Class: Nominal 2015 2014
value: £    £   
1 Share capital 1 1 - -
100 Share capital 2 0.01 1 1
1 1

3. ULTIMATE PARENT COMPANY

Navidea Biopharmaceuticals Inc (incorporated in USA ) is regarded by the director as being the
company's ultimate parent company.

Parent company accounts may be obtained from the following address;

5600 Blazer Parkway
Suite 200
Dublin
OH 43017

Page 3